|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4418 | |
| A61K 31/7076 | |||
| A61P 17/00 | |||
| A61Q 19/02 | |||
| A61Q 19/04 | |||
| A61K 8/49 | |||
| A61K 8/60 |
| (11) | Number of the document | 2456419 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10750183.5 |
| Date of filing the European patent application | 2010-07-20 | |
| (97) | Date of publication of the European application | 2012-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IL2010/000576 |
| Date | 2010-07-20 |
| (87) | Number | WO 2011/010306 |
| Date | 2011-01-27 |
| (30) | Number | Date | Country code |
| 227079 P | 2009-07-21 | US |
| (72) |
MADI, Lea Levana, IL
KORENSTEIN, Rafi, IL
|
| (73) |
Oradin Pharmaceutical Ltd.,
3 Recanati Street, 69494 Tel Aviv,
IL
|
| (54) | A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION |
| A3 ADENOSINE RECEPTOR LIGANDS FOR MODULATION OF PIGMENTATION |